Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05023005 · ClinicalTrials.gov registry record · NA
Strain-Counterstrain Treatment of Piriformis Pain
A NA study of Low Back Pain, Mechanical and Piriformis Syndrome, sponsored by Loma Linda University.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05023005: Recruiting NA study of Low Back Pain, Mechanical and Piriformis Syndrome, sponsored by Loma Linda University.
NCT05023005 is a NA study of Low Back Pain, Mechanical and Piriformis Syndrome that is actively recruiting participants, run by Loma Linda University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05023005, a NA study of Low Back Pain, Mechanical and Piriformis Syndrome, is actively recruiting participants, sponsored by Loma Linda University.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this investigator-initiated study is to provide an efficient and non-invasive treatment option for pain caused by the piriformis muscle.
Primary Outcome
Objective improvement in pressure/pain threshold
Conditions Studied
Interventions
- OTHER Strain-Counterstrain treatment of piriformis muscle
Study Locations (1)
California
- Loma Linda University Health - Loma Linda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-12 |
| Est. Completion | 2026-09 |
| Phase | NA |
What NCT05023005 shows while recruiting
NCT05023005 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Low Back Pain, Mechanical appearing as the primary indexed condition, and to 1 intervention - of which Strain-Counterstrain treatment of piriformis muscle is the first listed.
NCT05023005 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05023005 about?
NCT05023005 is a clinical study titled "Strain-Counterstrain Treatment of Piriformis Pain". The purpose of this investigator-initiated study is to provide an efficient and non-invasive treatment option for pain caused by the piriformis muscle.
What is the current status of trial NCT05023005?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-12. Estimated completion is 2026-09.
What conditions does trial NCT05023005 study?
This clinical trial studies the following conditions: Low Back Pain, Mechanical, Piriformis Syndrome, Somatic Dysfunction of Sacral Region (Finding).
What interventions are being tested in trial NCT05023005?
The interventions under investigation include: Strain-Counterstrain treatment of piriformis muscle (OTHER).
Who is sponsoring clinical trial NCT05023005?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05023005 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05023005's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia